As medical technology keeps improving, the life expectency of an average person keeps improving. Now there is a significant part of poulation which is old and sill active. This brings into prominence geriatric diseases (lieterally old age diseases), from a relatively unimportant disease category to a very important category.
Research has focused on Anti-aging compounds which help minimize /postpone these diseases. Anti-oxidants are widely given credit as protector of cells, health and are known to delay many diseases and aging. They do this by protecting cells against free radicals, which are produced naturally in our body. But the modern life with its attendant air pollution, asbestos, radiation and stress, etc., creates more free radicals which in turn fasten aging.
Our body naturally uses Vitamin C and E, besides Beta-carotene as anti-oxidant.When these become in short in body there is a build up of free radicals resulting in oxidative stress. UVrays induced skin damage also can be considerably reduced by anti-oxidants.
If there is build up of free radicals/toxins, glutathiones are given as supplements to control their effect.
Oxis International is one company which is creating therapeutic compounds in this space.Will this company be the penny stock which hits the jackpot?
Oxis International is the manufacturer of synthetic ergothioneine (their patent protected product) which is an anti oxidant supplement. They have other anti oxidant products meant for inflammatory bowel diseases like BTX-51072. They have lipid soluble anti oxidant compounds which mimics the activity of Vitamin E and are 20 to 40 times more potent than Vitamin E.
No comments:
Post a Comment